PYP Imaging in Conjunction with Cardiac Amyloid Clinic

PYP Imaging in Conjunction with Cardiac Amyloid Clinic Guest: Omar F. Abou Ezzeddine, M.D., C.M., M.S. (@abouezzeddine) Host: Paul A. Friedman, M.D. (@drpaulfriedman) There has been a revolution in the diagnosis of amyloid heart disease: Nuclear imaging has made endomyocardial biopsy the exception, rather than the rule. Joining us today to discuss the role of nuclear imaging in the diagnosis of amyloid heart disease is Omar F. Abou Ezzeddine, M.D., C.M., M.S., a consultant in Cardiovascular Medicine and director of the Cardiac Sarcoid Clinic at Mayo Clinic in Rochester, Minnesota. Specific topics discussed: Types of amyloid that infiltrate the heart muscle and cause myocardial toxicity Pyrophosphate (PYP) detection of those amyloids PYP imaging limitations and drawbacks, including risk of false-positives and false-negatives Limitations of single-photon emission computerized tomography (SPECT) imaging Pros and cons of hybrid SPECT-CT vs. SPECT-alone imaging Role of PYP imaging in assessment of therapeutic response Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV. NEW Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.